o2 multiplex massively parallel sequencing (Radboud University)
90
Structured Review
Radboud University
o2 multiplex massively parallel sequencing
O2 Multiplex Massively Parallel Sequencing, supplied by Radboud University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o2+multiplex+massively+parallel+sequencing/o2+multiplex+massively+parallel+sequencing/10__1007_slash_s10577___011___9214___7-231-3-30
Average 90 stars, based on 1 article reviews
O2 Multiplex Massively Parallel Sequencing, supplied by Radboud University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o2+multiplex+massively+parallel+sequencing/o2+multiplex+massively+parallel+sequencing/10__1007_slash_s10577___011___9214___7-231-3-30
Average 90 stars, based on 1 article reviews
o2 multiplex massively parallel sequencing - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Multiplex Assay:Article Title: Oral abstracts Article Snippet: Molecular karyotyping has moved from bench to bedside for the genetic screening of patients with intellectual disability and/or congenital anomalies (ID/CA).. The commercial availability of highresolution microarray platforms has significantly facilitated this process.. However, the notion that copy number variants (CNVs) are also abundantly present in the general population challenges the interpretation of the clinical significance of detected CNVs in these patients. Sequencing:Article Title: Oral abstracts Article Snippet: Molecular karyotyping has moved from bench to bedside for the genetic screening of patients with intellectual disability and/or congenital anomalies (ID/CA).. The commercial availability of highresolution microarray platforms has significantly facilitated this process.. However, the notion that copy number variants (CNVs) are also abundantly present in the general population challenges the interpretation of the clinical significance of detected CNVs in these patients. Biomarker Discovery:Article Title: Oral abstracts Article Snippet: Molecular karyotyping has moved from bench to bedside for the genetic screening of patients with intellectual disability and/or congenital anomalies (ID/CA).. The commercial availability of highresolution microarray platforms has significantly facilitated this process.. However, the notion that copy number variants (CNVs) are also abundantly present in the general population challenges the interpretation of the clinical significance of detected CNVs in these patients. Clinical Proteomics:Article Title: Oral abstracts Article Snippet: Molecular karyotyping has moved from bench to bedside for the genetic screening of patients with intellectual disability and/or congenital anomalies (ID/CA).. The commercial availability of highresolution microarray platforms has significantly facilitated this process.. However, the notion that copy number variants (CNVs) are also abundantly present in the general population challenges the interpretation of the clinical significance of detected CNVs in these patients. |